Clinical Trial

A Study of TPD3310 in Patients With Advanced Malignant Tumors

Name: A Study of TPD3310 in Patients With Advanced Malignant Tumors — clinical trial record (NCT07368127)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a multicenter, open phase I clinical study of dose escalation,cohort expansion study to evaluate the safety,tolerability,pharmacokinetics,pharmacodynamics, and preliminary efficacy of TPD3310 in patients withadvanced malignant solid tumors.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-21

Trial Details

NCT Number	NCT07368127
Lead Sponsor	TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
Conditions	Advanced Malignant Solid Tumors
Enrollment	112 participants
Start Date	2026-03-05
Primary Completion	2028-03-01 (estimated)
Study Completion	2029-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-20